Unknown OBSERVATIONAL NCT03269019

Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia

Sponsor: Wuhan Asia Heart Hospital

Conditions Biomarkers Heparin-Induced Thrombocytopenia Thrombosis

Updated 6 times since 2017 Last updated: Aug 30, 2017 Started: Nov 20, 2017 Primary completion: Aug 19, 2019 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Biomarkers and Heparin-Induced Thrombocytopenia and is currently ongoing. Wuhan Asia Heart Hospital leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Feb 2020 — Jan 2021 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Apr 2018 — Feb 2020 [monthly]

Not Yet Recruiting

Phase: NA → None

▶ Show 1 earlier version

Sep 2017 — Apr 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Wuhan Asia Heart Hospital

Data source: Wuhan Asia Heart Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.